Regions Financial Corporation · RF · FY2026 Q2 · Calendar Q3 2026
Regions Financial Q2 2026: EPS Beat, Record Wealth Quarter, Frazer Lanier Acquisition
Regions Financial delivered a solid Q2 2026 with an EPS beat of 7.6% and strong loan growth, particularly in commercial and small-business lending. The acquisition of Frazer Lanier expands municipal securities capabilities, while a new commercial lending platform and deposit transformation initiative underscore continued technology investment. Despite a modest negative market reaction and subsequent drift lower, management maintained a confident tone and reaffirmed full-year guidance, including a net interest margin target of approximately 3.7% by year-end.
Company context
Snapshot as of publicationRegions Financial Corporation (RF) operates as a financial holding company, delivering a comprehensive array of banking and related services to both individual consumers and corporate entities. The firm's operations are strategically divided into three principal divisions: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment specializes in commercial banking solutions. Its extensive offerings include various lending options such as commercial and industrial loans, commercial real estate financing, and investor real estate credit. Furthermore, it provides equipment lease financing, manages diverse deposit products, and offers sophisticated capital markets services like securities underwriting and placement, loan syndication, foreign exchange, derivatives, and merger and acquisition advisory, along with other consulting services. This segment primarily serves corporate clients, middle-market businesses, and developers and investors in commercial real estate.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Jul 21, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 21, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 7, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jul 6, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 6, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Jul 6, 2026 |
| Baird | Underperform | Neutral | Downgrade | Jul 6, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 29, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Mar 30, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jan 5, 2026 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Oct 14, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 22, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Oct 24, 2024 |
| Argus Research | Buy | Hold | Upgrade | Oct 24, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Oct 21, 2024 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Odeon Capital | Hold | Buy | Downgrade | Nov 13, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 1, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Nov 21, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 25, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 20, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 21, 2020 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 21, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 12, 2019 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 11, 2019 |
| Sandler O'Neill | Buy | Hold | Upgrade | Mar 25, 2019 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Apr 24, 2018 |
| FBR Capital | Neutral | Buy | Downgrade | Oct 10, 2017 |
| Susquehanna | Neutral | Positive | Downgrade | Dec 1, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Nov 16, 2016 |
| Bernstein | Market Perform | Outperform | Downgrade | Aug 16, 2016 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Jun 6, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Oct 8, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 8, 2015 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jan 21, 2015 |
| Wunderlich | Hold | Buy | Downgrade | Jan 21, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Aug 8, 2014 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Sandler O'Neil | Buy | Hold | Upgrade | Mar 6, 2013 |
| Rafferty Capital | Buy | Buy | Maintain | Feb 28, 2013 |
| Drexel Hamilton | Hold | Hold | Maintain | Oct 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $30.85. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Dave Rochester | $35 | $31.11 | +13.5% | Jul 21, 2026 |
| Truist Financial | Analyst unavailable | $34 | $31.11 | +10.2% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $34 | $31.3 | +10.2% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $34 | $31.65 | +10.2% | Jul 20, 2026 |
| Jefferies | David Chiaverini | $32 | $31.65 | +3.7% | Jul 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $34 | $30.92 | +10.2% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $30.36 | +0.5% | Jul 6, 2026 |
| D.A. Davidson | Analyst unavailable | $33 | $30.28 | +7.0% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $28 | $30.28 | -9.2% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $30.16 | +13.5% | Jun 29, 2026 |
| Truist Financial | Analyst unavailable | $30 | $28.41 | -2.8% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $31 | $28.38 | +0.5% | Apr 20, 2026 |
| D.A. Davidson | Analyst unavailable | $32 | $28.13 | +3.7% | Apr 20, 2026 |
| UBS | Analyst unavailable | $30 | $30.48 | -2.8% | Feb 4, 2026 |
| Piper Sandler | Analyst unavailable | $31 | $27.77 | +0.5% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $31 | $27.77 | +0.5% | Jan 19, 2026 |
| Wells Fargo | Analyst unavailable | $30 | $28.52 | -2.8% | Jan 16, 2026 |
| Goldman Sachs | Analyst unavailable | $32 | $28.18 | +3.7% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $30 | $27.56 | -2.8% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $29 | $27.78 | -6.0% | Dec 22, 2025 |
| Stephens | Analyst unavailable | $27 | $24.56 | -12.5% | Oct 14, 2025 |
| Evercore ISI | John Pancari | $29 | $26.5 | -6.0% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $26.63 | +3.7% | Sep 29, 2025 |
| Cantor Fitzgerald | Dave Rochester | $30 | $26.82 | -2.8% | Sep 9, 2025 |
| Barclays | Jason Goldberg | $27 | $26.24 | -12.5% | Jul 21, 2025 |
| Stephens | Terry McEvoy | $26 | $24.08 | -15.7% | Oct 29, 2024 |
| Argus Research | Kevin Heal | $26 | $23.78 | -15.7% | Oct 24, 2024 |
| Deutsche Bank | Matt O'Connor | $26 | $23.64 | -15.7% | Oct 24, 2024 |
| Truist Financial | Brandon King | $26 | $23.82 | -15.7% | Oct 21, 2024 |
| D.A. Davidson | Peter Winter | $29 | $23.82 | -6.0% | Oct 21, 2024 |
| Evercore ISI | John Pancari | $26 | $22.54 | -15.7% | Oct 2, 2024 |
| Wedbush | David Chiaverini | $28 | $22.91 | -9.2% | Sep 24, 2024 |
| Citigroup | Keith Horowitz | $26 | $22.72 | -15.7% | Sep 19, 2024 |
| Piper Sandler | Scott Siefers | $23 | $23.07 | -25.4% | Sep 3, 2024 |
| Morgan Stanley | Betsy Graseck | $28 | $22.43 | -9.2% | Jul 30, 2024 |
| D.A. Davidson | Peter Winter | $26 | $22.39 | -15.7% | Jul 22, 2024 |
| Truist Financial | Brandon King | $23 | $22.39 | -25.4% | Jul 22, 2024 |
| Robert W. Baird | David George | $21 | $22.09 | -31.9% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $23 | $22.09 | -25.4% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $22 | $22.09 | -28.7% | Jul 21, 2024 |
| Jefferies | Ken Usdin | $24 | $20.09 | -22.2% | Jul 3, 2024 |
| UBS | Erika Najarian | $22 | $20.51 | -28.7% | Apr 4, 2024 |
| Piper Sandler | Scott Siefers | $15 | $14.1 | -51.4% | Oct 25, 2023 |
| Barclays | Analyst unavailable | $29 | $21.92 | -6.0% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $25 | $20.71 | -19.0% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $28 | $20.4 | -9.2% | Dec 16, 2022 |
| Jefferies | Ken Usdin | $22 | $18.92 | -28.7% | Jul 11, 2022 |
| UBS | Erika Najarian | $32 | $24.59 | +3.7% | Jan 12, 2022 |
| Evercore ISI | John Pancari | $27 | $23.88 | -12.5% | Nov 16, 2021 |
| Odeon Capital Group LLC | Richard Bove | $27.7 | $23.8 | -10.2% | Nov 10, 2021 |
| Piper Sandler | Stephen Scouten | $28 | $23.85 | -9.2% | Oct 25, 2021 |
| Wells Fargo | Mike Mayo | $24 | $21.49 | -22.2% | Oct 4, 2021 |
| KBW | David Konrad | $18 | $19.12 | -41.7% | Jul 6, 2021 |
| Compass Point | Dave Rochester | $25 | $22.19 | -19.0% | May 18, 2021 |
Track every rating change on RF the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow RF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Q2 2026 adjusted earnings reached $583 million with a 20% return on tangible common equity. EPS of $0.68 exceeded the $0.632 consensus estimate by 7.6%, while revenue of $1.943 billion edged past the $1.936 billion estimate. Loan growth accelerated, driven by commercial and small-business segments with a high-quality credit mix. Wealth management delivered a record quarter, adding approximately $6 billion in assets under management. Non-interest-bearing deposits grew over 1% quarter-over-quarter. The bank completed a new commercial lending platform rollout and launched the deposit-conversion pilot ahead of full migration in 2027. The Frazer Lanier acquisition adds municipal securities underwriting capability. Compared to Q1, when EPS was $0.62 (up 11% YoY) and ROE was 18%, Q2 shows continued momentum in profitability and growth.
Guidance delta
Management maintained full-year guidance and reaffirmed key targets. The net interest margin target of approximately 3.7% by year-end was reiterated. Capital allocation priorities remain unchanged, with continued share repurchases while maintaining a CET1 ratio in the 9.25 to 9.75% range. The deposit transformation and core platform migration timeline was confirmed for mid-2027. Guidance sentiment remained maintained with no upward or downward revision from the prior quarter.
Key takeaways
- Adjusted earnings of $583 million with 20% return on tangible common equity.
- EPS of $0.68 beat consensus of $0.632 by 7.6%; revenue of $1.94B narrowly exceeded estimates.
- Loan growth accelerated, led by commercial and small-business lending with high-quality credit mix.
- Wealth management delivered a record quarter, adding approximately $6 billion in assets under management.
- Acquired Frazer Lanier Company to expand municipal securities underwriting capabilities.
- New commercial lending platform successfully implemented; deposit-conversion pilot launched ahead of 2027 migration.
Management priorities
- Complete deposit transformation and core platform migration by mid-2027.
- Integrate Frazer Lanier to grow the municipal finance franchise.
- Achieve net interest margin of approximately 3.7% by year-end.
- Continue share repurchases while maintaining CET1 in the 9.25 to 9.75% range.
- Invest in digital capabilities and expand wealth-management and capital-markets offerings.
Related earnings events
Financial ServicesSources
- Earnings call transcript and parsed analysis · 2026-07-17T16:03:48.243480+00:00
- FN2 earnings calendar · 2026-07-30T01:23:13.872335+00:00
- Polygon adjusted daily market bars · 2026-07-30T18:51:18.229337+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-30T18:51:18.226693+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.